Advanced Biomed Inc. Common Stock Cash Flow-to-Debt Ratio
Advanced Biomed Inc. Common Stock cash flow-to-debt ratio. Advanced Biomed Inc. Common Stock (ADVB) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of $-6.89K could theoretically repay 0% of its total liabilities ($1.44 Million) in one year. Check ADVB capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Advanced Biomed Inc. Common Stock (2021–2025)
Cash flow-to-debt ratio of Advanced Biomed Inc. Common Stock from 2021 to 2025. Historical debt coverage capacity for Advanced Biomed Inc. Common Stock across 5 annual periods. Check earnings quality score of Advanced Biomed Inc. Common Stock to evaluate the quality of earnings relative to operating cash generation.
Advanced Biomed Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2021–2025)
Advanced Biomed Inc. Common Stock cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for Advanced Biomed Inc. Common Stock. For the full cash flow conversion analysis, see Advanced Biomed Inc. Common Stock (ADVB) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | $-181.46K | $3.03 Million | ▲ +92.1% |
| 2024 | -0.76x | $-2.13 Million | $2.80 Million | ▲ +15.5% |
| 2023 | -0.90x | $-2.96 Million | $3.29 Million | ▼ -290.9% |
| 2022 | -0.23x | $-741.45K | $3.22 Million | ▲ +98.5% |
| 2021 | -15.73x | $-473.98K | $30.13K | — |